The Ogunnaike Lab seeks to advance convergent, translational, research on solid tumors and maternal diseases by harnessing immune and molecular engineering to better understand and improve the treatment efficacy of small molecule and immunotherapeutic agents. More broadly, our lab will use novel biomaterial and nanotechnology approaches for treating disease by developing immune-therapeutic interventions at the physical science-biomaterials-oncology interface. Specifically, the focus areas of our lab are to translate clinically focus therapies toward (i) understanding immune-material interactions to synthesize materials for novel immunotherapy delivery systems, (ii) developing innovative methods to isolate and probe normal-abnormal-host tissue interactions in healthy and diseased states, and (iii) delivering therapeutic payloads targeted to physiological immune/immune microenvironment for disease modulation.